Mycobacterium mucogenicum group infections: a review.
It has become apparent that Mycobacterium mucogenicum isolates recovered from clinical samples are more diverse than was previously realized and include an increasing number of emerging pathogens, as depicted by multilocus sequence analysis. Most clinically significant cases of those organisms involved catheter-related infections. They are susceptible to most antimicrobial agents, but like other rapidly growing mycobacteria, they are resistant to first-line antituberculous agents. A review of the cases of M. mucogenicum complex infection in the literature is addressed here, as well as two additional cases of the closely related species Mycobacterium aubagnense.
Division of Infectious Diseases, Emory Vaccine Center, Emory University School of Medicine, Atlanta, GA 30322, USA. tadekam@emory.edu
T
T
Adékambi
D000900:Anti-Bacterial Agents / Q000494:pharmacology; D000995:Antitubercular Agents / Q000494:pharmacology; D015373:Bacterial Typing Techniques; D055499:Catheter-Related Infections / Q000453:epidemiology / Q000382:microbiology; D016172:DNA Fingerprinting; D005838:Genotype; D006801:Humans; D009161:Mycobacterium / Q000145:classification / Q000187:drug effects / Q000302:isolation & purification*; D009164:Mycobacterium Infections / Q000453:epidemiology* / Q000382:microbiology*; D017422:Sequence Analysis, DNA
D000900:Anti-Bacterial Agents; D000995:Antitubercular Agents